Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,783 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $396.79 | 25 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $286.73 | 23 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $263.51 | 17 | $0 (2022) |
| Alkermes, Inc. | $201.50 | 10 | $0 (2019) |
| Allergan, Inc. | $153.36 | 9 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $79.20 | 6 | $0 (2020) |
| Lundbeck LLC | $68.90 | 4 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $58.45 | 3 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $54.23 | 3 | $0 (2019) |
| AbbVie Inc. | $37.55 | 2 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.34 | 2 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($28.34) |
| 2022 | $12.72 | 1 | Janssen Pharmaceuticals, Inc ($12.72) |
| 2021 | $121.76 | 7 | AbbVie Inc. ($37.55) |
| 2020 | $76.40 | 5 | Otsuka America Pharmaceutical, Inc. ($30.00) |
| 2019 | $656.09 | 39 | Alkermes, Inc. ($134.96) |
| 2018 | $548.91 | 36 | Otsuka America Pharmaceutical, Inc. ($192.47) |
| 2017 | $338.48 | 25 | Janssen Pharmaceuticals, Inc ($85.32) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/17/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: PSYCHIATRY | ||||||
| 09/15/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Neuroscience | ||||||
| 09/02/2021 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: PSYCHOLOGY | ||||||
| 08/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: NEUROSCIENCE | ||||||
| 07/28/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: CNS | ||||||
| 07/22/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, INVEGA | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Neuroscience | ||||||
| 06/25/2021 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: PSYCHIATRY | ||||||
| 06/03/2021 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: CNS | ||||||
| 03/02/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/05/2020 | Allergan, Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 01/10/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Central Nervous System | ||||||
| 01/08/2020 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CNS | ||||||
| 01/07/2020 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2019 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.22 | General |
| Category: CNS | ||||||
| 12/02/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: CNS | ||||||
| 10/30/2019 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), SPRAVATO | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: Neuroscience | ||||||
| 10/28/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: CNS | ||||||
| 10/17/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.81 | General |
| Category: CNS | ||||||
| 10/09/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CNS | ||||||
| 09/19/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: PSYCHIATRY | ||||||
| 09/12/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: CNS | ||||||
| 09/05/2019 | Takeda Pharmaceuticals U.S.A., Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.44 | General |
| Category: Central Nervous System (CNS) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 183 | 477 | $106,440 | $32,697 |
| 2022 | 8 | 194 | 486 | $81,872 | $29,351 |
| 2021 | 8 | 261 | 574 | $105,194 | $38,071 |
| 2020 | 8 | 297 | 763 | $128,252 | $48,459 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90870 | Therapy using electrical currents | Facility | 2023 | 17 | 152 | $48,944 | $11,882 | 24.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 24 | 95 | $15,204 | $5,637 | 37.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 32 | 52 | $14,309 | $4,534 | 31.7% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 28 | 30 | $8,670 | $3,977 | 45.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 49 | $5,738 | $2,000 | 34.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 34 | $5,654 | $1,714 | 30.3% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 42 | $4,250 | $1,593 | 37.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 23 | $3,671 | $1,361 | 37.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 31 | 118 | $15,576 | $6,393 | 41.0% |
| 90870 | Therapy using electrical currents | Facility | 2022 | 17 | 75 | $24,150 | $5,348 | 22.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 33 | 37 | $10,693 | $4,958 | 46.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 31 | 111 | $12,257 | $4,823 | 39.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 30 | 38 | $7,220 | $3,025 | 41.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 31 | $5,037 | $1,889 | 37.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 14 | 36 | $3,960 | $1,787 | 45.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 40 | $2,979 | $1,129 | 37.9% |
| 90870 | Shock treatment and monitoring | Facility | 2021 | 19 | 116 | $37,352 | $9,513 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 49 | 122 | $16,104 | $6,655 | 41.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 45 | 49 | $14,161 | $6,368 | 45.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 36 | 113 | $12,477 | $5,398 | 43.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 49 | 54 | $10,260 | $4,249 | 41.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 37 | $5,839 | $2,231 | 38.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 27 | 67 | $4,891 | $1,983 | 40.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 16 | $4,110 | $1,673 | 40.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 61 | 212 | $27,984 | $11,996 | 42.9% |
About Dr. Paul Epp, MD
Dr. Paul Epp, MD is a Psychiatry healthcare provider based in Saint Joseph, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770592461.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Epp, MD has received a total of $1,783 in payments from pharmaceutical and medical device companies, with $28.34 received in 2024. These payments were reported across 115 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,783).
As a Medicare-enrolled provider, Epp has provided services to 935 Medicare beneficiaries, totaling 2,300 services with total Medicare billing of $148,578. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Saint Joseph, MO
- Active Since 08/05/2006
- Last Updated 11/20/2017
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1770592461
Products in Payments
- LATUDA (Drug) $286.73
- ABILIFY MAINTENA (Drug) $270.93
- INVEGA SUSTENNA (Drug) $263.51
- REXULTI (Drug) $194.76
- VRAYLAR (Drug) $190.91
- ARISTADA (Drug) $134.96
- Aristada 441 mg (Drug) $66.54
- AUSTEDO (Drug) $66.02
- Trintellix (Drug) $58.45
- Fanapt (Drug) $54.23
- INGREZZA (Drug) $32.33
- NeuroStar TMS Therapy (Device) $31.36
- CAPLYTA (Drug) $28.34
- NUEDEXTA (Drug) $26.90
- VYVANSE (Drug) $24.57
- Adzenys XR-ODT (Drug) $14.71
- QELBREE (Drug) $13.25
- AJOVY (Biological) $13.18
- NUPLAZID (Drug) $11.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Joseph
Dr. Donald Hinton, M.d, M.D
Psychiatry — Payments: $801.75
Emad Khan, Md, MD
Psychiatry — Payments: $729.90
Dr. Alan Anderson, D.o, D.O
Psychiatry — Payments: $556.43
Dr. Matthew Perry, Md, MD
Psychiatry — Payments: $440.60
Dr. Ali Syed, Do, DO
Psychiatry — Payments: $206.54
Richard Lecuru, Md, MD
Psychiatry — Payments: $32.64